Northwestern Mutual Wealth Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
GS
SCM
VPM
VCM
WP
SL
Northwestern Mutual Wealth Management's RCUS Position: Q1 2026 in Review
Northwestern Mutual Wealth Management increased its Arcus Biosciences (RCUS) stake by 800% in Q1 2026, buying an estimated $173 and bringing the position to 9 shares worth $194. The position accounts for ﹤0.01% of the portfolio, ranked #3943.
Northwestern Mutual Wealth Management first reported a position in RCUS in Q2 2021 and has held it in 20 quarters since. The position peaked at $64K in Q2 2021. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.
- Northwestern Mutual Wealth Management held 9 shares of Arcus Biosciences worth $194 as of Q1 2026.
- Northwestern Mutual Wealth Management bought 8 Arcus Biosciences shares in Q1 2026, an estimated $173.
- Arcus Biosciences made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3943 holding.
- Northwestern Mutual Wealth Management first reported a position in Arcus Biosciences in Q2 2021 and has held it in 20 quarters since.
- Northwestern Mutual Wealth Management's Arcus Biosciences position peaked at $64K in Q2 2021.
- 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.